Evidence map›Paper›PMID 41113329›Full record

ArticleOpen forum infectious diseases2025

Characteristics of In- and Off-season Respiratory Syncytial Virus Episodes-United States, 2016-2020.

Jennifer Judy, Kari Yacisin, Jessica E Atwell, Elizabeth Begier, Daniel Curcio, Alejandro Cané

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jennifer JudyPfizer Global Respiratory Vaccines and Antivirals, Real World and Core Evidence, Remote, MD, USA.ORCID https://orcid.org/0000-0002-2246-9745
Kari YacisinPfizer Vaccines, US Medical Affairs, Collegeville, PA, USA.
Jessica E AtwellPfizer Vaccines, Global Medical Affairs, Remote, AZ, USA.ORCID https://orcid.org/0000-0003-1169-6456
Elizabeth BegierPfizer Vaccines, Global Medical Affairs, Dublin, Ireland.ORCID https://orcid.org/0000-0002-1287-5416
Daniel CurcioPfizer Vaccines, Global Medical Affairs, Madrid, Spain.ORCID https://orcid.org/0000-0002-3387-2433
Alejandro CanéPfizer Vaccines, US Medical Affairs, Collegeville, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In temperate climates, respiratory syncytial virus (RSV) can occur outside the typical fall/winter/spring season. Using the Premier Healthcare Database, we identified and described hospital-based RSV episodes in the US prior to the COVID-19 pandemic (2017-2020), comparing narrowly-defined in-season (December-February) and off-season (June-August) episodes. We identified 141 427 in-season and 3756 off-season episodes among children (<18 years) and 41 735 in-season and 1243 off-season episodes among adults. Among pediatric episodes, most in- and off-season (60%, 59%) were infants. Black and Hispanic pediatric patients were over-represented in off- versus in-season episodes (Black: 22% vs 15%; Hispanic 30% vs 19%; P < .0001). Trends were similar for adults. A higher proportion of off-season pediatric episodes included antibiotics (54% vs 45%; P < .0001), and among infants and children 1-4 years, were more likely to be individuals with congenital or chronic conditions (P < .0001). Disparities due to race, ethnicity, and underlying conditions were identified among off-season cases.

Indexed as

respiratory syncytial virusRSVseasonality

Identifiers

PMID41113329
PMCPMC12534730

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.